The FDA is cracking down on telehealth companies marketing compounded versions of weight loss drugs by warning them against false claims and scrutinizing their clinical affiliations, while a key U.S. federal vaccine advisory panel has abandoned efforts to discourage mRNA vaccines under new leadership. Content creators should be cautious about promoting health-related products or services that are subject to regulatory scrutiny and ensure accuracy in their representations.
Read the full article at STAT Pharma
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
9
Comments
Ali NematiWritten by Ali
